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Abstract
Background: Overall cancer incidence rates decreased in the most recent time period in both men and women,
largely due to improvements in surgical therapeutic approaches (tertiary prevention) and screening programs
(secondary prevention), but differences in cancer incidence and survival according to socioeconomic status are
documented worldwide. Health risk behaviors, defined as habits or practices that increase an individual’s likelihood
of harmful health outcomes, are thought to mediate such inequalities.
Discussion: Obesity has been related with increased cancer incidence and mortality due to imbalance of leptin
and adiponectin which are connected to activation of PI3K, MAPK, and STAT3 pathways and decreasing insulin/
insulin-like growth factor (IGF)-1 and mTOR signaling via activation of 5 AMP-activated protein kinase (AMPK),
respectively. Physical activity has been associated to prevent cancer by the aforementioned obesity-related
mechanisms, but also increasing level of circulating vitamin D, which has been related to lower risk of several
cancers, and increasing prostaglandin F2a and reducing prostaglandin E2, which are both related with cancer
prevention and promotion, respectively. A large number of different substances may induce themselves a direct
cytotoxicity and mutagenic action on cells by smoking, whereas alcohol promote immune suppression, the delay
of DNA repair, inhibition of the detoxification of carcinogens, the production of acetaldehyde, and the contribution
to abnormal DNA methylation. The combined smoking and alcohol drinking habits have been shown to increase
cancer risk by smoke action of increasing the acetaldehyde burden following alcohol consumption and alcohol
action of enhancing the activation of various procarcinogens contained in tobacco smoke.
Conclusions: Interventions at the social level may be done to increase awareness about cancer risks and promote
changing in unhealthy behaviors.
Background
Cancer is a leading cause of death worldwide, accounting
for 7.6 million deaths (around 13% of all deaths) [1]. Over-
all cancer incidence rates decreased in the most recent
time period in both men and women, largely due to
decreases in the 3 major cancer sites in men (lung, pros-
tate, and colorectum) and 2 major cancer sites in women
(breast and colorectum) [2]. It has been documented that
a decrease has been reached also in mortality rates, mostly
due to improvements in surgical therapeutic approaches
[3-5]. However, different outcomes have been reported
due to non-modifiable factors such age [6,7] and increased
cancer mortality due to modifiable factors, such as the
socioeconomic status, has been well documented world-
wide, irrespectively of national health-care system [8-10].
Social disparities in cancer survival are multidimensional
and may depend on factors related to the public health
care organization [11]. These factors may regard screen-
ing, diagnosis conditions, access to specialized care, treat-
ment or follow-up modalities, and they vary according to
the health care systems [12]. In countries where the insur-
ance status is crucial for access and continuity of care,
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increased financial resources may support patients to bet-
ter manage the disease [13,14]. Many evidences have
demonstrated inequalities by socioeconomic status and
race. Several studies have reported inequalities at different
levels, for instance in delay of hospitalization or advanced
cancer stage at diagnosis for disadvantaged groups [15,16].
Similar trends have been reported regarding survival of
cancer patients, evidencing inequalities among lower
socioeconomic classes and economically disadvantaged
race and ethnicity groups [17,18]. Cultural disparities may
depend on a different access to health information. In
example, higher education has been associated with
increased internet use and high eHealth literacy which is
related to have increased knowledge and previous screen-
ing practice related to colorectal cancer compared to
those with low eHealth literacy [19]. A higher education
and knowledge about colorectal cancer related informa-
tion has been also related with an increased acceptance of
colorectal cancer screening programs [20]. On the other
hand, in countries with equal access to health-care facil-
ities, a direct economic hindrance in seeking medical
health care cannot be relevant, because health-care facil-
ities are tax-financed. Thus, socioeconomic and cultural
status may act by psychosocial pathways. More accultu-
rated people may have higher knowledge about health-
related topics, be more aware of their symptoms and
communicate better with health staff than low-cultural
people [21,22]. Health risk behaviors are defined as habits
or practices that increase an individual’s likelihood of
harmful health outcomes. They are thought to explain, at
least in part, many social inequalities in health status of
populations. It has been reported that health risk beha-
viors, including diet, physical activity, and smoking,
explain the higher frequencies of several cancers and mor-
tality among those of lower socio-economic status [23].
On the other hand, although many of these factors are
modifiable causes of cancer, it is challenging to plan inter-
ventions acting on the specific associations between them
and cancer over a lifetime, due to the long latent period
for cancer development and its complex pathogenesis.
Thus, the only possibility to prevent cancer is to increase
awareness in people regarding health-related behaviors in
order to establish life-long habits that may decrease the
risk of developing malignancies. As most of cancer-
promoting factors are related with the social status of one
person, we will discuss of the main well-recognized cause
of cancer which may mediate social and cultural effects on
cancer developing and survival.
Obesity
Obesity has dramatically increased during the last few
decades both in developed and now also in developing
countries, contributing to the global rising of cardiovas-
cular diseases [24]. Nowadays, it has been estimated that
overweight population increased in European countries
ranging between 8% and 40% in men and between 5%
and 53% in women [25], whereas in the United States
reached the 66% of adults with a BMI >25 kg/m2 and
half of those have a BMI of >30 kg/m2 [26]. The fast
rise of obesity in Western countries cannot be related
with a genetic mutation due to the high rapidity of the
phenomenon. Conversely, over the past few decades, the
transformation of the modern environment leaded to
changes in diet and physical activity.
Obesity has been widely associated with non-communic-
able diseases, such as cardiovascular diseases (heart disease
and stroke), diabetes, osteoarthritis and musculoskeletal
disorders, fatty liver, gall stones, psychological disorders,
and psychosocial problems [27] as well as it has been also
related to increased mortality [28]. Obesity has been also
associated to a higher incidence of many cancers, including
cancers of the endometrium, kidney, gallbladder (in
women), breast, colon, and esophagus [29], and increased
cancer-related mortality [30]. An indirect association
between obesity and diet quality may explain the increased
risk of cancer [30,31], since the lacking of healthy nutrients
may occurs in subjects consuming low-quality diet [31-36].
On the other hand, despite the biological mechanisms
explaining the direct relationship between obesity and can-
cer are still unclear, several hypotheses have been proposed
[37]. As adipose tissue is an endocrine organ that produces
and secretes polypeptide hormones (i.e., leptin and adipo-
nectin), it has been hypothesized that imbalance of produc-
tion of such hormones may be involved in cancer
development [38,39]. Specifically, a pro-carcinogenic effect
of leptin has been demonstrated by activation of PI3K,
MAPK, and STAT3 pathways [40-42] whereas adiponectin
may exert anticancer effects by decreasing insulin/insulin-
like growth factor (IGF)-1 and mTOR signaling via activa-
tion of 5 AMP-activated protein kinase (AMPK) and exert-
ing anti-inflammatory actions via the inhibition of nuclear
factor kappa-light-chain-enhancer of activated B cells
(NF-B) [43]. Also steroid hormones, including estrogen,
progesterone, androgens, and adrenal steroids are asso-
ciated with adipose tissue [44] and may play a role on pro-
gression of several types of male and female cancer [45].
An inflammation theory for cancer development
related to obesity has been also hypothesized. Indeed,
the increased levels of proinflammatory cytokines and
various interleukins related to body adiposity, may sti-
mulate the activation of NF-B complex which may
promote cancer development itself [46].
Hyperinsulinemia and elevated IGF-1 are related to
the diabetic condition and the obese status. Both insulin
and IGF-1 have been hypothesized to play a role on
cancer promotion through the Akt/PI3K/mTOR cascade
that promotes cell growth and proliferation [47,48]. On
the contrary, caloric restriction induce the disruption of
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the Akt/PI3K/mTOR cascade at least in part via AMPK
activation [49,50] and is frequently associated with a
decreased cancer incidence of breast cancer in humans
and in animal models [51,52]. Interestingly, similar path-
ways are involved in cancer promotion and progression
irrespectively of the primary cause, thus suggesting a
possible target for therapy [53,54].
Obesity has been related also to decreased survival in
patients affected by several types of cancers [55,56]
although no study has elucidated the causal mechanism
and there is currently no evidence that weight loss after
diagnosis improves survival. Considerations regarding
obese patients are focused on chemotherapy, radiotherapy,
and surgical treatment [34]. Concerns of relative over-
(due to increased weight) or under-dosing (to avoid toxi-
city) of chemotherapy in the obese cancer patients have
been reported [57]. Moreover, technical difficulties in posi-
tioning obese patients during radiotherapy may occur [58].
Finally, high BMI has been strongly, but not univocally,
predictive of worse operative outcomes [59].
Physical activity
A protective association between physical activity and
colon, breast, ovarian, lung, and renal cancers is supported
by a number of review articles [60-67]. Similar effects have
been demonstrated also in prolonging survival in cancer
patients [68]. Unlike these consistently observed findings,
the association with rectal cancer is still uncertain [69]
maybe due to the different carcinogenic mechanisms
related with the cancer location. Main hypothesized
mechanisms include those aforementioned obesity-related
such as decreased adipose tissue accumulation, decreased
inflammation, reduced levels of insulin and IGF- 1 and
modulated immune response [70]. Physical activity also
increase level of circulating vitamin D [71], which has a
direct anti-carcinogenic effect on colonic epithelial cells
[72] and has been related to lower risk of colon, renal, and
other cancers [73-75]. Moreover, the decreased bowel
transit time induced by physical activity reduce the expo-
sure of the colon to colonic contents, bile acids and other
potential carcinogens [76]. Finally, physical activity has
been also related to increased prostaglandin F2a [77] and
reduced prostaglandin E2 [78] that are both related with
cancer prevention and promotion, respectively [79].
Smoking and alcohol drinking
Several reports seem to demonstrate the detrimental
effects of smoke on health, increasing risk of many can-
cers, including lung, laryngeal and pharyngeal, followed by
upper digestive tract and oral cancers [80], as well as blad-
der [81] renal [82], breast [83], and colorectal cancers [84].
Despite the pathogenicity of tobacco smoking for pulmon-
ary and urologic cancers appears well understood, doubts
on the precise biological mechanisms on colorectal cancer
promotion and progression still exist. The way by which
cigarette smoking may induce lung malignancy includes a
large number of different substances, most of them cur-
rently unknown, that may induce themselves a direct cyto-
toxicity and mutagenic action on lung epithelial cells by
means of generation of DNA mutations, epigenetic events,
epithelial cell to mesenchymal cell transformations, as well
as by chronic cell damage [85,86]. Regarding low digestive
tract cancers, epidemiological data revealed that a long
period of exposure is required to increase risk of colon
cancer [87]. It has been hypothesized that the possibility of
proto-oncogene mutation in gastrointestinal mucosa cells
may be associated with tobacco smoking-induced cancers
through the formation of unfavorable DNA adducts [88].
Moreover, the association of smoking with rectal cancer
seems to be stronger than with colon [87,89].
Alcohol has been reported to cause nearly 4% of the
global cancer burden [90], and chronic consumption has
been associated with cancers of the oral cavity, larynx,
pharynx, esophagus, liver, colon, rectum, and breast
[91]. Some meta-analyses of case-control [92] and
cohort studies [93-95] concluded that a daily alcohol
intake of 25-30 g or more is significantly associated with
increased risk of colon and rectal cancer, suggesting a
linear dose-response relationship. The mechanisms
hypothesized to play a role in cancer promotion involve
the immune suppression, the delay of DNA repair, the
induction of cytochrome P-450 enzymes that inhibit the
detoxification of carcinogens (including nitrosamine),
the changes in bile acid composition, the production of
acetaldehyde (a known carcinogen implicated in colorec-
tal carcinogenesis), and the contribution to abnormal
DNA methylation [96,97]. Moreover, alcohol may
enhance the penetration of other carcinogenic molecules
into mucosal cells by acting as a solvent and may stimu-
late regenerative cell growth by various cytotoxic
mechanisms including the excess production of oxygen
free radicals [97].
The combined smoking and alcohol drinking habits
have been shown to be detrimental for health and notably
increase cancer risk by smoke action of increasing the
acetaldehyde burden following alcohol consumption and
alcohol action of enhancing the activation of various pro-
carcinogens contained in tobacco smoke due to increased
metabolic activation by an induced cytochrome P450-2E1-
dependent microsomal biotransformation system in the
mucosa of the upper digestive tract and the liver [98].
Recommendations and conclusions
The most recognized interventions on cancer prevention
regard secondary prevention, such as screening pro-
grams. These interventions aim to diagnose the malig-
nancies at an early stage and to treat these lesions before
spread occurs. On the other hand, they do not interfere
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with factors which may play a role in the genesis and pro-
motion of the disease. Primary prevention may reduce
the exposure to cancer-promoting environmental and
behavioral influences [99].
A series of intervention through public health policy
can be made in order to decrease cancer risk among gen-
eral population. Regarding smoking habit, a six-point
intervention list has been developed by the World Health
Organization and focus on the following main features:
monitor tobacco use and prevention policies; protect
people from tobacco smoke; offer help to quit tobacco
use; warn about the dangers of tobacco; enforce bans on
tobacco advertising, promotion, and sponsorship; and
raise taxes on tobacco [100]. Public policy options for
alcohol control include, as well as with tobacco control,
availability and taxation, for example by reducing retail
hours and density of alcohol outlets, which has been
reported to reduce sales and consumption [101-103].
Moreover, interventions at the social level may be done
to discourage consumption. Public health efforts should
be made in order to ameliorate the environmental con-
text for healthy eating by providing easier access and
price incentives for healthy foods such as fruit and vege-
tables. Interventions on food advertising have been
demonstrated to be effective in increase diet quality and
reduce obesity rates [104]. Moreover, education on maxi-
mizing opportunities for physical activity, such as
encouraging stair use over elevators, may help people to
maintain a healthy weight.
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